Figure 1.
CIR, NRM, RFS, and OS showing differential effects of T cell depletion between CMV seropositive and seronegative recipients
(A-B) Cumulative incidence of relapse, (C-D) Non-relapse mortality, (E-F) Relapse free survival, and (G-H) Over all survival.